Cited by 940SARS-CoV-2 and COVID-19 ResearchCOVID-19 epidemiological studiesCOVID-19 Clinical Research Studies

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.

Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers

Open access

Lumley, Sheila F., O’Donnell, Denise, Stoesser, Nicole E., Matthews, Philippa C., Howarth, Alison, Hatch, Stephanie B., Marsden, Brian D., Cox, Stuart, James, Tim, Warren, Fiona, Peck, Liam J., Ritter, Thomas G., de Toledo, Zoe, Warren, Laura, Axten, David, Cornall, Richard J., Jones, E. Yvonne, Stuart, David I., Screaton, Gavin, Ebner, Daniel, Hoosdally, Sarah, Chand, Meera, Crook, Derrick W., O’Donnell, Anne-Marie, Conlon, Christopher P., Pouwels, Koen B., Walker, A. Sarah, Peto, Tim E.A., Hopkins, Susan, Walker, Timothy M., Jeffery, Katie, Eyre, David W.·2021·New England Journal of Medicine

DOI 10.1056/nejmoa2034545PMC PMC7781098

Published version of a preprint

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: The relationship between the presence of antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the risk of subsequent reinfection remains unclear. METHODS: We investigated the incidence of SARS-CoV-2 infection confirmed by polymerase chain reaction (PCR) in seropositive and seronegative health care workers attending testing of asymptomatic and symptomatic staff at Oxford University Hospitals in the United Kingdom. Baseline antibody status was determined by anti-spike (primary analysis) and anti-nucleocapsid IgG assays, and staff members were followed for up to 31 weeks. We estimated the relative incidence of PCR-positive test results and new symptomatic infection according to antibody status, adjusting for age, participant-reported gender, and changes in incidence over time. RESULTS: A total of 12,541 health care workers participated and had anti-spike IgG measured; 11,364 were followed up after negative antibody results and 1265 after positive results, including 88 in whom seroconversion occurred during follow-up. A total of 223 anti-spike-seronegative health care workers had a positive PCR test (1.09 per 10,000 days at risk), 100 during screening while they were asymptomatic and 123 while symptomatic, whereas 2 anti-spike-seropositive health care workers had a positive PCR test (0.13 per 10,000 days at risk), and both workers were asymptomatic when tested (adjusted incidence rate ratio, 0.11; 95% confidence interval, 0.03 to 0.44; P = 0.002). There were no symptomatic infections in workers with anti-spike antibodies. Rate ratios were similar when the anti-nucleocapsid IgG assay was used alone or in combination with the anti-spike IgG assay to determine baseline status. CONCLUSIONS: The presence of anti-spike or anti-nucleocapsid IgG antibodies was associated with a substantially reduced risk of SARS-CoV-2 reinfection in the ensuing 6 months. (Funded by the U.K. Government Department of Health and Social Care and others.).

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1056/nejmoa2034545

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study
To, K. K., Tsang, O. T.-Y., Leung, W.-S., Tam, A. R., Wu, T.-C., Lung, D. C., Yip, C. C., Cai, J., Chan, J. M., Chik, T. S., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30196-1 · Cited by 3,045
Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections
Long, Q.-X., Tang, X.-J., Shi, Q.-L., Li, Q., Deng, H.-J., Yuan, J., Hu, J.-L., Xu, W., Zhang, Y., Lv, F.-J., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0965-6 · Cited by 2,686
Convergent Antibody Responses to SARS-CoV-2 in Convalescent Individuals
Robbiani, D. F., Gaebler, C., Muecksch, F., Lorenzi, J. C. C., Wang, Z., Cho, A., Agudelo, M., Barnes, C. O., Gazumyan, A., Finkin, S., et al. (2020) · Nature · doi:10.1038/s41586-020-2456-9 · Cited by 1,853
Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans
Seow, J., Graham, C., Merrick, B., Acors, S., Pickering, S., Steel, K. J. A., Hemmings, O., O’Byrne, A., Kouphou, N., Galao, R. P., et al. (2020) · Nature Microbiology · doi:10.1038/s41564-020-00813-8 · Cited by 1,419
Robust neutralizing antibodies to SARS-CoV-2 infection persist for months
Wajnberg, A., Amanat, F., Firpo, A., Altman, D. R., Bailey, M. J., Mansour, M., McMahon, M., Meade, P., Mendu, D. R., Muellers, K., et al. (2020) · Science · doi:10.1126/science.abd7728 · Cited by 1,195
Humoral Immune Response to SARS-CoV-2 in Iceland
Gudbjartsson, D. F., Norddahl, G. L., Melsted, P., Gunnarsdottir, K., Holm, H., Eythorsson, E., Arnthorsson, A. O., Helgason, D., Bjarnadottir, K., Ingvarsson, R. F., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2026116 · Cited by 903
Vaccines: Correlates of Vaccine‐Induced Immunity
Plotkin, S. A. (2008) · Clinical Infectious Diseases · doi:10.1086/589862 · Cited by 829
Genomic evidence for reinfection with SARS-CoV-2: a case study
Tillett, R. L., Sevinsky, J. R., Hartley, P. D., Kerwin, H., Crawford, N. F., Gorzalski, A. J., Laverdure, C., Verma, S. C., Rossetto, C. C., Jackson, D. K., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30764-7 · Cited by 755
Coronavirus Disease 2019 (COVID-19) Re-infection by a Phylogenetically Distinct Severe Acute Respiratory Syndrome Coronavirus 2 Strain Confirmed by Whole Genome Sequencing
To, K. K.-W., Hung, I. F.-N., Ip, J. D., Chu, A. W.-H., Chan, W.-M., Tam, A. R., Fong, C. H.-Y., Yuan, S., Tsoi, H.-W., Ng, A. C.-K., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1275 · Cited by 746
Neutralizing antibodies correlate with protection from SARS-CoV-2 in humans during a fishery vessel outbreak with a high attack rate
Addetia, A., Crawford, K. H. D., Dingens, A., Zhu, H., Roychoudhury, P., Huang, M.-L., Jerome, K. R., Bloom, J. D., & Greninger, A. L. (2020) · Journal of Clinical Microbiology · doi:10.1128/jcm.02107-20 · Cited by 525

Show all 29 references

Research works printed but not linked: 2

Muecksch F, Wise H, Batchelor B, et al. Longitudinal analysis of serology and neutralizing antibody levels in COVID19 convalescents. J Infect Dis 2020 November 3 (Epub ahead of print).33140086
To KK-W, Hung IF-N, Ip JD, et al. COVID-19 re-infection by a phylogenetically distinct SARS-coronavirus-2 strain confirmed by whole genome sequencing. Clin Infect Dis 2020 August 25 (Epub ahead of print).32840608

Sorted by citations

Items 801–900 of 913

COMO A TECNOLOGIA FARMACÊUTICA PODE AUXILIAR NO DESENVOLVIMENTO DE NOVOS MEDICAMENTOS ANTIVIRAIS? (PARTE 2)
da Costa, L. A. G., de Souza, C. G., Ferreira, A. S., de Araújo, L. V., Souza, A. T. M., & Neto, P. J. R. (2022) · Latin American Publicações eBooks · doi:10.47174/lap2020.ed.00000111
H1N1
Bernardo, R. N., Aguiar, M. A. M. D. S., Ferreira, A. L., & dos Santos, K. M. (2022) · Latin American Publicações eBooks · doi:10.47174/lap2020.ed.00000100
COVID-19: IMPORTÂNCIA E AVANÇOS NO DIAGNÓSTICO DA DOENÇA
da Rosa, M. M., Pereira, M. C., Cunha, E. G. C., Albuquerque, A. P. D. B., de Oliveira, P. S. S., Carvalho, L. V. D. N., Tavares, L. B., Costa, N. T. C., de Paula, S. K. S., de Carvalho, V. M. F., et al. (2022) · Latin American Publicações eBooks · doi:10.47174/lap2020.ed.0000094
ARBOVIROSES: ASPECTOS VIRAIS, ECOLÓGICOS, CLÍNICOS E EPIDEMIOLÓGICOS
de Oliveira, M. E. D. S. P., de Lima, M. V. D. S. A., de Assunção, M. A. S., & LIMA, V. K. D. A. (2022) · Latin American Publicações eBooks · doi:10.47174/lap2020.ed.00000102
CHIKUNGUNYA: DA EPIDEMIOLOGIA AO DESENVOLVIMENTO DE VACINAS
Purificação, A., Azevedo, E. D. A. N., Lins, R. D., & Viana, I. F. T. (2022) · Latin American Publicações eBooks · doi:10.47174/lap2020.ed.00000105
FATORES DE VIRULÊNCIA VIRAIS NA COVID-19
Farias, P. C. S., da Rocha, D. A. M., Feitosa, A. P. S., Alves, L. C., & Brayner, F. A. (2022) · Latin American Publicações eBooks · doi:10.47174/lap2020.ed.0000096
HEPATITE C
Caliari, V. D. A., Muniz, D. D. M., Cavalcanti, J. V. C., Saraiva, P. R. B. D. C., Arruda, A. T. C., Melo, J. V. A. S. N. D., Arruda, A. G. T. C., & Neto, J. R. D. E. (2022) · Latin American Publicações eBooks · doi:10.47174/lap2020.ed.00000108
CARACTERÍSTICAS CLÍNICAS DA COVID-19
da Rosa, M. M., Pereira, M. C., Pessoa-e-Silva, R., Sá, J. L. F., Silva, R. C., Mendonça, A. C. S., Lima, C. A. D. O., Ferreira, M. D. A., Rego, M. J. B. M., & Pitta, M. G. D. R. (2022) · Latin American Publicações eBooks · doi:10.47174/lap2020.ed.0000095
Prevention and Infection Control
Ingebretson, E. (2022) · Springer eBooks · doi:10.1007/978-3-030-94740-8_2
Natural humoral immunity per year after SARS-CoV-2 infection in hospitalized patients
Cabanes, L., Rubio, C., Martínez, O., & Naval, E. (2022) · Enfermedades infecciosas y microbiologia clinica (English ed ) · doi:10.1016/j.eimce.2022.04.007
SARS-CoV-2 seroprevalence and characteristics of post-infection immunity in a general population cohort study in Catalonia, Spain.Preprint
Karachaliou, M., Moncunill, G., Espinosa, A., Castaño‐Vinyals, G., Jiménez, A., Vidal, M., Santano, R., Barrios, D., Puyol, L., Carreras, A., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-448363/v2
Antibody response after one and two doses of the BNT162b2 vaccine in nursing home residents: The CONsort-19 studyPreprint
Bousquet, J. J., Blain, H., Tuaillon, É., Gamon, L., Pisoni, A., Miot, S., Rolland, Y., & Picot, M. (2021) · doi:10.22541/au.162041939.97098496/v1
LES VACCINS anti-SARS-Cov-2 et LES QUESTIONS QU'ILS EVOQUENTPreprint
Labdi, A. (2021) · OSF Preprints (OSF Preprints) · doi:10.31219/osf.io/4x763
Cumulative Incidence of SARS-CoV-2 Infection and Associated Risk Factors Among Frontline Health Care Workers in Paris, France: The SEROCOV Prospective Cohort StudyPreprint
Hausfater, P., Boutolleau, D., Lacombe, K., Beurton, A., Dumont, M., Constantin, J., Ghosn, J., Combes, A., Cury, N., Guedj, R., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-960512/v1
Severe acute respiratory syndrome coronavirus 2 antibody prevalence in adult patients with short bowel syndrome—A German multicenter cross‐sectional study
Blüthner, E., Pape, U., Blumenstein, I., Wichmann, J., Tacke, F., & Moosburner, S. (2022) · Journal of Parenteral and Enteral Nutrition · doi:10.1002/jpen.2410
SARS-COV-2 ANTIGEN SCREENING DURING THE FIRST POST-LOCKDOWN MAJOR MUSIC FESTIVAL IN NOVI SAD, SERBIA, IN JULY 2021
Lazović, M., Bojat, V., Vuković, V., Smiljanic, N., Milić, M., Velicki, R., Nikolić, N., Pustahija, T., & Ristić, M. (2022) · Facta Universitatis Series Medicine and Biology · doi:10.22190/fumb220507001l
Pre-Vaccination Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Seroprevalence in Workers at Three Japanese Hospitals
Takayama, Y., Komatsu, T., Wada, T., Nihonyanagi, S., Hoshiyama, T., Moriya, T., Shimamura, S., Kajigaya, N., Naito, M., Takeuchi, O., et al. (2022) · Journal of Nippon Medical School · doi:10.1272/jnms.jnms.2022_89-511
Role of Functional Food Additives in Regulating the Immune Response to COVID-19
Verma, R., & Bagel, M. P. (2022) · Current Biotechnology · doi:10.2174/2211550111666220613143422
Sağlık Personelinde COVID-19 Aşısı Sonrası Spike Antikor Düzeyleri Ne Durumda?
Kaya, Ş., Yıldırım, M. S., Kavak, Ş., Alakuş, F., Güleken, M. D., Mertsoy, Y., Altındağ, R., Asena, M., & Kaya, Ş. (2022) · Turkish Journal of Clinics and Laboratory · doi:10.18663/tjcl.909402
Um Modelo Matemático Discreto do tipo SIR aplicado à dados de casos da COVID-19 no Estado de Mato Grosso
de Azevedo, J. A., de Assis, L. M. E., & de Assis, R. A. (2022) · INTERMATHS Revista de Matemática Aplicada e Interdisciplinar · doi:10.22481/intermaths.v3i1.10279
Reinfection, recontamination and revaccination for SARS-CoV-2
Kullmann, T., & Drozgyik, A. (2022) · World Journal of Methodology · doi:10.5662/wjm.v12.i4.258
SARS-CoV-2 Antibody Status after the BNT162b2 Vaccine in Healthcare Workers
Onishi, S., YAMAZAKI, A., Kikuchi, K., Shimamura, Y., Sugaya, F., & Anbo, Y. (2022) · Japanese Journal of Infection Prevention and Control · doi:10.4058/jsei.37.10
Prevalence of Immunoglobulin (G (IgG) and M (IgM)) Against SARS-COV-2 and risk factors for positivity among Students at tertiary education institution, MalawiPreprint
Mwale, S. E., Chisale, M., Chimenya, M., Tandwe, T. N. G., Chapeta, Y., Nkosi, M. M., Nyambalo, B. W., Ngonga, J., Munyenyembe, P., Kayange, W., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1870665/v1
COVID-19 Disease
Conlon, C. P., & Firth, J. D. (2020) · doi:10.1093/med/9780198746690.003.0650_update_002
Self-citation
Elevated Levels of Anti-SARS-Cov2 IgG Antibody in Health Care Workers in Hospitals From Hamadan Province, Iran: A Prospective Study
Jalili, E., Bashirian, S., Faryabi, M. R., Noroozbeygi, M., Daneshyar, E., Ghelichkhani, S., Khazaei, S., & Solgi, G. (2022) · Avicenna Journal of Clinical Microbiology and Infection · doi:10.34172/ajcmi.2022.13
Risiko Infeksi COVID-19 pada Tenaga Kesehatan di Rumah Sakit dengan Riwayat Infeksi atau Vaksinasi COVID-19: Systematic Review
Putri, K., Wibowo, A., & Taufik, M. I. S. (2022) · Media Publikasi Promosi Kesehatan Indonesia (MPPKI) · doi:10.56338/mppki.v5i1.1881
Outcome after single dose of ChAdOx1 vaccine against SARS-CoV-2 infection at 16 weeks post-vaccination among healthy adults in Saudi Arabia
Alghamdi, A., Al-Sanea, N. A., Alraey, M. A., Joseph, M. V., Aboud, M., Almangour, T. A., Alharbi, W., Alhumidan, H., Alanizi, A. H., & Al-Jedai, A. H. (2022) · Annals of Saudi Medicine · doi:10.5144/0256-4947.2022.223
A Social Network Analysis of COVID-19 Transmission Models in Taiwan: Two Epidemic Waves in 2020-2021
Hsieh, P.-H. H. P.-H., & Hsieh, C.-H. L. P.-H. (2022) · 網際網路技術學刊 · doi:10.53106/160792642022092305009
Comparative IgG responses to SARS-CoV-2 after natural infection or vaccinationPreprint
Olds, K. M., Humphreys, D. P., Gavin, K. M., Wyllie, A. L., & Bauer, T. A. (2022) · medRxiv · doi:10.1101/2022.09.28.22280476
Likelihood of COVID-19 reinfection in an urban community cohort in Massachusetts
Casey, S. M., Legler, A., Hanchate, A. D., & Perkins, R. B. (2022) · Dialogues in Health · doi:10.1016/j.dialog.2022.100057 · Cited by 1
Antibody level against COVID-19 among the vaccinated infected and non-infected doctors by SARS-COV-2: A Comparative study
Akhter, N., Mollah, F. H., Jahan, N., Adam, J., Hossain, M. A., & Chowdhury, M. Z. (2022) · Update Dental College Journal · doi:10.3329/updcj.v12i2.59770
SEMI-QUANTITATIVE ANALYSIS OF SARS-COV-2 IGG ANTIBODIES FOLLOWING CHADOX1-NCOV (COVISHIELD™) VACCINATION
M, R. K., Doddamani, P. K., Kishanrao, N. R., Parandekar, P., JISHA, M., Narayana, M., & MAHADEVAIAH, P. (2022) · Asian Journal of Pharmaceutical and Clinical Research · doi:10.22159/ajpcr.2022.v15i10.45452
Evaluation of Humoral immune responses against coronavirus in healthcare staff in hospitals and medical centers of Shahrekord University of Medical Sciences, Iran
Asadi-Samani, M., Soltani, M., Rahmani, F., Kheiri, S., & Moradi, M.-T. (2022) · Journal of Shahrekord University of Medical Sciences · doi:10.34172/jsums.2022.27
Cellular immune response to combined DNA-protein constructs carrying SARS-CoV-2 antigens
Zadorozhny, A. M., Borgoyakova, M. B., Starostina, E. V., & Карпенко, Л. И. (2022) · Medical academic journal · doi:10.17816/maj108654
COVID-19 Geçiren, CoronaVac ve BNT162b2 Aşı olan Bireylerde Hümoral İmmün Yanıtın Değerlendirilmesi
Gareayaghi, N., Dinç, H. Ö., Özbey, D., Akçin, R., Daşdemir, F. O., Akkus, S., Eryiğit, Ö. Y., & Kocazeybek, B. (2022) · Harran Üniversitesi Tıp Fakültesi Dergisi · doi:10.35440/hutfd.1138445
II. COVID-19: How Far Has the Pathogenesis been Elucidated?
Ohmagari, N. (2021) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.110.2355
The Effectiveness of COVID-19 Vaccine in Healthcare Workers: Does Gender Matter?
Ulusoy, T. Ü., Şencan, İ., Altay, F. A., Callak, F., SEVİNÇ, G., TEKİN, A., & Hekimoğlu, C. H. (2022) · Turkish Bulletin of Hygiene and Experimental Biology · doi:10.5505/turkhijyen.2022.82956
COVID Immunity
Hazarika, B. (2022) · Assam Journal of Internal Medicine · doi:10.4103/2278-8239.361831
Prognosis in COVID-19 Patients: Statistics, Risk Factors
Sosnowska, B., Bielecka-Dabrowa, A. M., & Banach, M. (2022) · Contemporary cardiology · doi:10.1007/978-3-031-15478-2_5
Evaluating the Value of Anti-SARS-CoV-2 Antibody Detection and Neutralizing Responses With Euvirus: A Population of 10776 Close Contacts in Delta Variant Epidemic of Fujian
Zeng, Y., Lin, C., Liu, C., Chun, H., Chen, F., Cao, Y., Wu, S., Wei, D., Lin, Z., Zhang, Y., et al. (2022) · Clinica Chimica Acta · doi:10.1016/j.cca.2022.12.017
Monitoreo serológico y psicológico en personal de salud durante el comienzo de la pandemia COVID-19
Elizondo, C. M., Thomas, D. S., Peroni, L., Manelli, R. P., Arrigo, D., Seoane, F., Rolan, M., Gimenez, M. I., Asprea, V., Sanchez, M., et al. (2022) · Revista del Hospital Italiano de Buenos Aires · doi:10.51987/revhospitalbaires.v42i4.185
Distributed Ledgers and Immunity Passports: The Intersection of Clinical Medicine and Digital Technology
Firstenberg, M. S., Wilson, B., McCallister, D. E., & Stawicki, S. P. (2023) · Integrated science · doi:10.1007/978-3-031-14591-9_6
Is Vaccination of Children Against Covid-19 Warranted?
Rai, S. K., Kant, S., Jha, S., & Dasgupta, R. (2023) · Indian Journal of Community Medicine · doi:10.4103/ijcm.ijcm_443_22
Ex Vivo Immune Responsiveness to SARS-CoV-2 Omicron BA.5.1 Following Vaccination with Unmodified mRNA-Vaccine
Kuechler, A. S., Heger, E., Wirtz, M., Weinhold, S., Uhrberg, M., Boege, F., & Schulze-Bosse, K. (2023) · Vaccines · doi:10.3390/vaccines11030598
Immunology of COVID-19
Wallis, R. S., Srivastava, A. K., Wack, A., & Knirsch, C. A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-87539-4.00003-8
A FIOCRUZ Mato Grosso do Sul e o enfrentamento à covid-19
Guilhermino, J. D. F., Mendes, F. M. L., & Benevides, P. J. C. (2023) · doi:10.18310/9786554620390
One-Year Follow-Up of Seroprevalence of SARS-CoV-2 Infection and Anxiety among Health Workers of a French Cancer Center: The PRO-SERO-COV Study
Richez, B., Cantarel, C., Durrieu, F., Soubeyran, I., Blanchi, J., Pernot, S., Chakiba, C., Roubaud, G., Cousin, S., Étienne, G., et al. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20115949
Investigation of the Change in Antibody Levels of COVID-19 RT-PCR Positive Patients Over Time
Çöplü, N., Kılınç, Ç., Özbek, R., Demir, C., Çalışır, B., & AHLATCIOGLU, Z. A. (2023) · Flora the Journal of Infectious Diseases and Clinical Microbiology · doi:10.5578/flora.20239915
Relating the SARS-CoV-2 Spike Protein to Infectivity, Pathogenicity, and Immunogenicity in COVID-19
Nikhra, V. (2021) · Annals of Immunology & Immunotherapy · doi:10.23880/aii-16000131
SARS-CoV-2 Antibody Response to the Sputnik Vaccine in Previous Infected Patients and Non-Infected One
Abdulsamad, M., Ebrahim, F., Tabal, S., Bashir, S., Aburgiga, A., Milad, M., & Bareem, M. (2023) · Archives of Clinical and Medical Microbiology · doi:10.33140/acmmj.02.02.01
Shadow of a Pandemic: Persistence of Prenatal SARS-CoV-2 Antibodies in Newborn Blood Spots
Sciortino, S., Graham, S., Fillman, T. J., Kandasamy, H., Cooley, R., Hanson, C. V., Eckert, V., Tang, H. T., Yang, J., Seftel, D., et al. (2023) · International Journal of Neonatal Screening · doi:10.3390/ijns9030043
DYNAMICS OF ANTI-SPIKE PROTEIN IGG ANTIBODY LEVELS OVER A 10-MONTH PERIOD FOLLOWING VACCINATION OR INFECTION – A RETROSPECTIVE STUDY
Ciomaga, B.-F., Pascu, C., & Ionescu, G. O. (2022) · Romanian Archives of Microbiology and Immunology · doi:10.54044/rami.2022.03.02
Effect of Vaccination Status on SARS-CoV-2 Antibody Levels in Gowa Regency Community, Indonesia
Ilmy, A. A. M., Ridwan, Zulkifli, A., Arsin, A. A., Syam, A., & Seweng, A. (2023) · International Journal of Statistics in Medical Research · doi:10.6000/1929-6029.2023.12.11
Can long-term COVID-19 vaccination be improved by serological surveillance?: a modeling study for MozambiquePreprint
Liu, C. Y., Shioda, K., Kraay, A. N. M., Massora, S., de Jesus, Á., Massinga, A. J., Monjane, C., Omer, S. B., Jenness, S. M., Nelson, K., et al. (2023) · medRxiv · doi:10.1101/2023.08.29.23294793
Short-term SARS-CoV-2 Re-infection Rate in Vaccinated Health Workers based on Received Vaccines: A Cross-sectional Study
Sinaei, R., Jafari, M., Karamozian, R., Pezeshki, S., Sinaei, R., Robati, F. K., Yeganeh, M. H., & Najafzadeh, M. J. (2023) · Current Respiratory Medicine Reviews · doi:10.2174/1573398x19666230911094423
Evaluation of Vaccination and Polymerase Chain Reaction Test Positivity of Hospital Personnel During the COVID-19 Pandemic
Aslan, Y., Sevim, E., & GÜLER, S. (2023) · Acibadem Universitesi Saglik Bilimleri Dergisi · doi:10.31067/acusaglik.1259681
COVID-19 Vaccination: Infectivity and Symptomaticity of SARS- COV-2 among residents in Bonny Island, Rivers State, Nigeria
Ogbondah, B. O., Owhonda, G. C., Luke, A., Jaja, I. D., Green, P., & Pius, O. M. (2023) · Ibom Medical Journal · doi:10.61386/imj.v16i2.307
Rapid COVID-19 immunity screening by machine learning aided multiplexed nanoplasmonic biosensor
Beisenova, A., Adi, W., Bashar, S. J., Velmurugan, M., Germanson, K. B., Shelef, M. A., & Yesilköy, F. (2023) · Plasmonics: Design, Materials, Fabrication, Characterization, and Applications · doi:10.1117/12.2676173
Protection against symptomatic SARS-CoV-2 infection during the second wave among individuals with pre-existing binding antibodies to SARS-CoV-2: A population-based study from Puducherry, India
Ramasubramani, P., Govindan, D., Krishnan, N. B., Kadhiravan, T., & Kar, S. S. (2023) · Asian Pacific Journal of Tropical Medicine · doi:10.4103/1995-7645.380727
The prevalence of COVID-19 among healthcare professionals at primary healthcare centers
Zayer, R. H. (2023) · South Asian Journal of Social Sciences and Humanities · doi:10.48165/sajssh.2023.4605
Beyond the waves: Unraveling pandemic outcomes with genomic insights and immunity analysis – Evidence from 14 countries
Jang, Y.-A., Wu, H.-Y., Hsu, Y., Chen, Y., Chiou, H.-Y., Sytwu, H., Chen, W. J., & Tsou, H. (2023) · Preventive Medicine · doi:10.1016/j.ypmed.2023.107820
SERUM IGM AND IGG TITERS 2 WEEKS AND 8 WEEKS FROM BEGINNING OF SYMPTOMS AND THEIR RELATION TO SEVERITY IN COVID-19
Amin, S., Al-Shaikhani, M., & Abdulrahman, R. (2023) · Journal of Sulaimani Medical College · doi:10.17656/jsmc.10421
Basic Characteristics of Dynamical Systems
Trzaska, Z. W. (2023) · Studies in systems, decision and control · doi:10.1007/978-3-031-39985-5_1
Clinical and laboratory considerations: determining an antibody-based composite correlate of risk for reinfection with SARS-CoV-2 or severe COVID-19
Holdenrieder, S., Ferreira, C. E. D. S., Izopet, J., Theel, E. S., & Wieser, A. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1290402
Quizizz Paper Media in Improving Understading of Tayamum
Triyuniarti, H., Fadila, N., Tabroni, I., Kathryn, M., & Cale, W. (2023) · Journal Emerging Technologies in Education · doi:10.55849/jete.v1i2.379
Comparison of Effectivenness Between Ibuprofen and Paracetamol in the Treatment of Fever in Children Aged 0-18 Years a Systematic Review and Meta-Analysis of Randomized Control Trials
Fibritiani, A. (2023) · Journal of World Future Medicine Health and Nursing · doi:10.55849/health.v1i2.432
Importancia de la diferenciación de la respuesta inmune humoral entre individuos convalecientes, vacunados, y casos incidentes de COVID-19
Duarte, L. F., Vásquez, Y., Diethelm‐Varela, B., Riedel, C. A., Bueno, S. M., & González, P. A. (2023) · Revista del Instituto de Salud Pública de Chile · doi:10.34052/rispch.v7i1.163
İnaktif SARS-CoV-2 Aşısı Uygulanan Sağlık Çalışanlarında Anti-Spike S1 RBD IgG Değerlerinin Belirlenmesi
BÜLBÜL, K., Bozok, T., Kaya, H., GÜLBUDAK, H., Ülger, S. T., & Aslan, G. (2024) · Black Sea Journal of Health Science · doi:10.19127/bshealthscience.1387834
Risk factors contributing to infection with SARS-CoV-2 are modulated by sex
Lecona, O. A., Arroyo-Valerio, A., Bueno-Hernández, N., Carrillo-Ruiz, J. D., Ruelas, L., Márquez-Franco, R., Aguado-García, A., Barrón-Palma, E. V., Escobedo, G., Ibarra‐Coronado, E., et al. (2024) · PLoS ONE · doi:10.1371/journal.pone.0297901
Coupled dynamics of the spread of COVID-19, interventions and human behaviour
Iftekhar, E. N. (2024) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-10390
Dynamics of formation of anti- bodies to SARS-CoV-2 after coronavirus infection in children
Bogomolova, I. K., & Peregoedova, V. N. (2024) · Perm Medical Journal · doi:10.17816/pmj41113-23
Post-vaccination SARS-CoV-2 IgG spike antibody responses among clinical and non-clinical healthcare workers at a tertiary facility in Kenya
Mwangi, L. W., Omuse, G., Adam, R. D., Ong’ete, G., Matheka, C., Mugaine, P., Sayed, S., & Maina, D. (2024) · PLoS ONE · doi:10.1371/journal.pone.0299302
Additional file 1 of RBD-specific antibody responses after two doses of BBIBP-CorV (Sinopharm, Beijing CNBG) vaccine
Ferenci, T., & Sarkadi, B. (2022) · Figshare · doi:10.6084/m9.figshare.19029488
COVID-19 vaccine hesitancy, safety and effectiveness
(2024) · Frontiers research topics · doi:10.3389/978-2-8325-4812-7
Serosurveillance of COVID-19 amongst health care workers in a teaching institution – A prospective cohort study in Puducherry district
Kamaludeen, M., Ranganadin, P., Pillai, A. B., & Sugumaran, A. (2024) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_1488_23
COVID-19 Pandemic as a mass killer and existential public health emergency in Nigeria remains unproven: A viewpoint
Okoro, E., Salihu, M. O., Akpila, A. S., & Giwa, A. O. (2022) · Sahel Medical Journal · doi:10.4103/smj.smj_71_21
Koronavirüs, Grip/Nezle ve Hastalanmamış Bireylerin Obsesif-Kompulsif Bozukluk Belirtileri ve Ruminasyon Açısından Karşılaştırılması
Özcan, A., Aydın, H., Baç, D. Z., Karaağaç, N., & Gültepe, B. (2024) · Kalem Uluslararasi Egitim ve Insan Bilimleri Dergisi · doi:10.23863/kalem.2024.290
The Predictors of COVID-19 Immunogenicity Elicited by Vaccines Against SARS-CoV-2 in Stem Cell Transplant Recipients
Elbahr, U. S., Erdem, H., Ankaralı, H. Ç., -, C. E. P. D. L. R., PASTRANA, J., Vineeth, C., HEJRES, S., Kaynar, L., ÖZTÜRK, Ç. P., Abalı, H., et al. (2024) · Flora the Journal of Infectious Diseases and Clinical Microbiology · doi:10.5578/flora.202402994
Antibody response to SARS-CoV-2 natural and breakthrough infection in patients undergoing maintenance hemodialysis: A prospective cohort study over 4 months
Chen, Y., Zhang, X., Zhou, M., Wu, P., Yan, J., Sun, C., Zhang, Y., & Zheng, X. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e38545
The Trajectory of Antibody Responses One Year Following SARS-CoV-2 Infection among Indigenous Individuals in the Southwest United States
Smith, C. P., Hartman, R. M., Kugler, A. M., Little, V., Baker, O. R., Fairlie, T. A., Fernández, R. E., Hagen, M. B., Honie, E., Laeyendecker, O. B., et al. (2024) · Viruses · doi:10.3390/v16101573
Observational Report on Functional SARS-CoV-2 Immune Responses in Immune Competent and Compromised IndividualsPreprint
Peek, L. J., Patrick, A. L., Givens, N., D’Alessio, B., Weaver, A., Jackson, L. P., White, T. J., & Pestano, G. A. (2024) · medRxiv · doi:10.1101/2024.11.08.24316708
Quantitative and qualitative analysis of seroconversion after one year of vaccination with inactivated SARS-CoV-2 vaccine (CoronaVac®) in healthcare workers: Cross-sectional analytical study
da Silva, J. G., Arruk, V. G., da Veiga, G. L., Sousa, L. V. D. A., Alves, B. D. C. A., Fonseca, F. L. A., & van der Heijden, I. M. (2024) · Journal of Virological Methods · doi:10.1016/j.jviromet.2024.115067
Novel Coronavirus Infection COVID-19 and the Status of Humoral Immune Response in Patients with Hematologic Malignancies
Игнатьева, Е. В., Анатольевич, Р. О., & Казаков, С. П. (2024) · Clinical oncohematology · doi:10.21320/2500-2139-2024-17-4-415-421
Proteome-Wide Analysis of Antibody Responses in Asymptomatic Omicron BA.2-Infected Individuals at the Amino Acid Resolution
Wang, H., Gao, H., Li, M., Cheng, L., Zhang, X., Zhang, X., Zhan, H., Liu, Y., Wang, Y., Ren, J., et al. (2024) · Journal of Proteome Research · doi:10.1021/acs.jproteome.4c00546
Re-Infection of COVID-19 in Lao health care workers: Vientiane capital, Champasak and Luangphabang, Lao PDR
Soukhasem, T., Soukavong, M., & Ounavong, A. (2024) · International Journal of Public Health Asia Pacific (IJPHAP) · doi:10.62992/2a5wha16
Determination of t cell immune response to SARS-CoV-2 coronavirus based on induced γ-interferon production by specific T cells upon their stimulation by viral antigen
Сергеевич, Ч. Б., Kudryashova, A. M., Pankratyeva, L. L., Васильевна, Б. А., Manuylov, V. A., Gushchin, V. А., Pochtovyi, A. A., Borisova, O. V., & Свитич, О. А. (2024) · Medical Immunology (Russia) · doi:10.15789/1563-0625-dot-3007
Antibody response after SARS-CoV-2 infection or vaccination in China: A cross-sectional study
Zhu, P., Chen, Y., Xu, X., Tan, D., Xiao, L., Liao, C.-L., Xia, H., Zhang, T., Zou, J., Chen, X., et al. (2025) · Vaccine X · doi:10.1016/j.jvacx.2025.100644
Teamwork makes the dream work : systemic and mucosal immunity in shaping protection against SARS-CoV-2
Marking, U. W. (2025) · doi:10.69622/28194125.v1
T cell immunity induced by SARS-CoV-2 and flavivirus vaccination
Wullimann, D. (2025) · doi:10.69622/28287788.v1
Investigation on the Inhibitory Effect of Bergenia purpurascens Water Extract on COVID-19 XBB1.5 Variant and Its Blocking ACE2 Mechanism
Shi, Y., Sun, X., Yu, Z., Dai, D., Guo, H., Mei, L., Dai, J., & Jiang, L. (2025) · Natural Product Communications · doi:10.1177/1934578x251327922
COVID-19 Disease
Conlon, C. P., & Firth, J. D. (2020) · doi:10.1093/med/9780198746690.003.0650_update_003
Self-citation
Assessment of SARS-CoV-2 Infection, Vaccination, and Immunity Status Among a Population of Dentists/Academic Professors in a Clinical Setting: One-Year Findings
Manarte-Monteiro, P., Marques, G. B., Alves, D., Duro, M., Domingues, J., Gavinha, S., da Silva, L. P., & Teixeira, L. (2025) · COVID · doi:10.3390/covid5080120
Distinct features of humoral and cellular immunity against Omicron breakthrough infection among chronic liver disease patients: An experience from a follow-up cohort
Liu, Y., Shi, Y., Zhan, H., Wang, Y., Yuan, W., Xie, Y., Cheng, L., Guo, X., Li, X., Kang, H., et al. (2025) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2025.2544466
COVID-19 vaccination-infection status and immunological profile from India: A case study for prioritizing at risk population for targeted immunization
Gujjarlapudi, D., Mittal, A., Raju, V. D. G., Veturi, S. Y., Talukdar, R., Banerjee, R., Jagtap, N., Krishnaiah, S., Veeraiah, N., & Duvvur, N. R. (2025) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_1977_24
Avoir été malade de la Covid-19 ne protège pas aussi bien qu’un vaccin, surtout face au variant Delta
Grier, J. T. (2021) · The Conversation · doi:10.64628/aak.mert735x6
Reinfecção e infecção pós-vacinal por SARS-CoV-2 em profissionais de enfermagem: estudo de coorte prospectiva, Recife, 2020-2023
Verissimo, T. M. D. S. M., Montarroyos, U. R., Montenegro, D., Neto, C. L. F., & Araujo, C. (2025) · Epidemiologia e Serviços de Saúde · doi:10.1590/s2237-96222025v34e20240162.pt
Reinfection and post-vaccination infection by SARS-CoV-2 in nursing professionals: a prospective cohort study, Recife, 2020-2023
Verissimo, T. M. D. S. M., Montarroyos, U. R., Montenegro, D., Neto, C. L. F., & Araujo, C. (2025) · Epidemiologia e Serviços de Saúde · doi:10.1590/s2237-96222025v34e20240162.en
Baseline Anti-SARS-CoV-2 IgG and Protection from Symptomatic Infection: Post Hoc Analysis of the SCTV01E Phase 3 Randomized Trial
Yan, L., Yi, J., Liu, D., Li, J., Baidoo, A. A. H., & Xie, L. (2025) · Vaccines · doi:10.3390/vaccines13090984
Response Rates in a COVID-19 Seroepidemiological Survey in Nigeria: Variations by State, Age Group, and Urban-Rural Settings
Osuolale, K. A., Ojogbede, A. K., Musa, A. Z., Aina, O. O., Bamidele, T. A., Amoo, O. S., Okwuraiwe, A. P., Raheem, T. Y., Nwachukwu, W. E., Ochu, C. L., et al. (2025) · Science Journal of Public Health · doi:10.11648/j.sjph.20251301.11
Live microbials to boost Anti-SARS-CoV-2 immunity clinical trial (Live BASIC trial): a triple-blind randomized controlled trial
Horton, D. B., Ukey, R., Madhvi, A., Andrews, T., Parmar, V., Reilly, N., Mäkelä, S. M., Peterson, J., Hustad, L., Wong, G., et al. (2025) · Infection · doi:10.1007/s15010-025-02697-4

Authors: Lumley, S. F., O’Donnell, D., Stoesser, N. E., Matthews, P. C., Howarth, A., Hatch, S. B., Marsden, B. D., Cox, S., James, T., Warren, F., Peck, L. J., Ritter, T. G., de Toledo, Z., Warren, L., Axten, D., Cornall, R. J., Jones, E. Y., Stuart, D. I., Screaton, G., Ebner, D., Hoosdally, S., Chand, M., Crook, D. W., O’Donnell, A.-M., Conlon, C. P., Pouwels, K. B., Walker, A. S., Peto, T. E. A., Hopkins, S., Walker, T. M., Jeffery, K., & Eyre, D. W.
Affiliations: Public Health England (GB)
From Oxford University Hospitals NHS Foundation Trust (S.F.L., N.E.S., P.C.M., S.C., T.J., F.W., L.W., D.A., A.-M.O., K.J.), Nuffield Department of Medicine (S.F.L., D.O., N.E.S., P.C.M., A.H., S.B.H., B.D.M., R.J.C., E.Y.J., D.I.S., G.S., D.E., S. Hoosdally, D.W.C., C.P.C., A.S.W., T.E.A.P., T.M.W.), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (N.E.S., P.C.M., S. Hoosdally, D.W.C., A.S.W., T.E.A.P., D.W.E.), the Kennedy Institute of Rheumatology Research (B.D...
Corresponding author: Eyre, David W.
ORCID: Lumley, Sheila F.
Stoesser, Nicole E.
Matthews, Philippa C.
Hatch, Stephanie B.
Marsden, Brian D.
Peck, Liam J.
Ritter, Thomas G.
Cornall, Richard J.
Stuart, David I.
Screaton, Gavin
Ebner, Daniel
Hoosdally, Sarah
Chand, Meera
Crook, Derrick W.
Conlon, Christopher P.
Pouwels, Koen B.
Walker, A. Sarah
Peto, Tim E.A.
Hopkins, Susan
Jeffery, Katie
Eyre, David W.
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2021-02-11
Volume: 384
Issue: 6
Pages: 533-540
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejmoa2034545
PMC: PMC7781098
OpenAlex: W3117382778
Cited by: 940
References: 29
Citations by year: 2026: 7 · 2025: 26 · 2024: 53 · 2023: 103 · 2022: 299 · 2021: 434
FWCI: 28.01
Type: journal article
Language: en
Open access: green
doi.org
Licence: cc-by
www.nejmgroup.org/legal/terms-of-use.htm (vor)
Locations: New England Journal of Medicine (publishedVersion)
medRxiv (acceptedVersion, cc-by)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
UCL Discovery (University College London) (submittedVersion)
Funders: U.K. Government
Topics: Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
Physical Sciences › Mathematics › Modeling and Simulation › COVID-19 epidemiological studies
Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
Keywords: SARS-CoV-2, COVID-19 reinfection, healthcare workers, anti-spike IgG, seropositivity, seroconversion, asymptomatic infection, symptomatic infection, infection incidence, antibody status
MeSH terms: Seroconversion, COVID-19, SARS-CoV-2, Coronavirus Nucleocapsid Proteins, COVID-19 Nucleic Acid Testing, COVID-19 Serological Testing, Adolescent, Adult, Aged, Aged, 80 and over, Antibodies, Viral, Female, United Kingdom, Health Personnel, Humans, Immunoglobulin G, Longitudinal Studies, Male, Middle Aged, Recurrence, Incidence, Polymerase Chain Reaction, Young Adult, Spike Glycoprotein, Coronavirus

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks